|
Lipids and Lipid Disorders
Citations 1-10 of 264 total displayed.
|
Most recent content
(18 Nov 2009):
|
- Original Contributions
Trends in High Levels of Low-Density Lipoprotein Cholesterol in the United States, 1999-2006
- Elena V. Kuklina; Paula W. Yoon; Nora L. Keenan
JAMA 2009; 302: 2104-2110.
[Abstract]
[Full text]
[PDF]
[ JAMA Report Video ]
- Commentaries
Primary Prevention of Cardiovascular Disease: Time to Get More or Less Personal?
- Aroon D. Hingorani; Bruce M. Psaty
JAMA 2009; 302: 2144-2145.
[Extract]
[Full text]
[PDF]
- Editorials
Simplifying the Approach to the Management of Dyslipidemia
- J. Michael Gaziano; Thomas A. Gaziano
JAMA 2009; 302: 2148-2149.
[Extract]
[Full text]
[PDF]
|
Past content
(since Feb 1998):
|
- Original Contributions
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- The Emerging Risk Factors Collaboration
JAMA 2009; 302: 1993-2000.
[Abstract]
[Full text]
[PDF]
[ eSupplement ]
- Original Contributions
Statin Use and Risk of Gallstone Disease Followed by Cholecystectomy
- Michael Bodmer; Yolanda B. Brauchli; Stephan Krähenbühl; Susan S. Jick; Christoph R. Meier
JAMA 2009; 302: 2001-2007.
[Abstract]
[Full text]
[PDF]
[ eFigure and eTables ] [ JAMA Report Video ]
- Original Contributions
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
- Christoph U. Correll; Peter Manu; Vladimir Olshanskiy; Barbara Napolitano; John M. Kane; Anil K. Malhotra
JAMA 2009; 302: 1765-1773.
[Abstract]
[Full text]
[PDF]
[ eTables ]
- Editorials
Implications of Marked Weight Gain Associated With Atypical Antipsychotic Medications in Children and Adolescents
- Christopher K. Varley; Jon McClellan
JAMA 2009; 302: 1811-1812.
[Extract]
[Full text]
[PDF]
- Letters
Lipoprotein(a) Measurement and Determining Risk of Myocardial Infarction—Reply
- Pia R. Kamstrup; Børge G. Nordestgaard
JAMA 2009; 302: 1645-a-1646-a.
[Extract]
[Full text]
[PDF]
- Letters
Lipoprotein(a) Measurement and Determining Risk of Myocardial Infarction
- Steven R. Jones; Roger S. Blumenthal
JAMA 2009; 302: 1645.
[Extract]
[Full text]
[PDF]
- Preliminary Communications
Vascular Abnormalities, Paraoxonase Activity, and Dysfunctional HDL in Primary Antiphospholipid Syndrome
- Marietta Charakida; Christian Besler; Joana R. Batuca; Shirish Sangle; Susanna Marques; Miguel Sousa; Guosu Wang; Dimitris Tousoulis; Jose Delgado Alves; Stavros P. Loukogeorgakis; Charles Mackworth-Young; David D’Cruz; Thomas Luscher; Ulf Landmesser; John E. Deanfield
JAMA 2009; 302: 1210-1217.
[Abstract]
[Full text]
[PDF]
|
|
